News about "Granules Pharmaceuticals Inc"

Granules Pharmaceuticals, Inc. Successfully Completes USFDA Post-Marketing Adverse Drug Experience (PADE) Inspection with Zero Observations

Granules Pharmaceuticals, Inc. Successfully Completes USFDA Post-Marketing Adverse Drug Experience (PADE) Inspection with Zero Observations

Zero Observations indicate a commitment to the highest level of patient safety and product quality

Granules Pharmaceuticals Inc | 04/08/2023 | By Sudeep Soparkar 492


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members